Insmed Incorporated

NasdaqGS:INSM

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 27.01 B

Share Price

USD 127.80

Avg Daily Volume

3,808,951

Change (1 day)

0.04%

Change (1 year)

72.38%

Change (YTD)

85.11%

Insmed Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -234.81%

Insmed Incorporated EBITDA Margin is -234.81% for the Trailing 12 Months (TTM) ending June 30, 2025, a 9.23% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Insmed Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -214.97%, a -6.35% change year over year.
Insmed Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -229.55%, a 36.63% change year over year.
Insmed Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -168.02%, a -10.79% change year over year.
Insmed Incorporated EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -188.34%, a 54.31% change year over year.